MedTrace Logo

The Maintenance Treatment of UFT in Advanced Gastric Cancer

NCT02903498 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2016-10-12

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and tolerability of the maintenance treatment of tegafur-uracil (UFT) after the standard first-line chemotherapy in advanced gastric cancer.

Conditions

Interventions

DRUG

UFT

UFT 360mg/m2 qd po d1-14, q3w

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Principal Investigators

  • Xiaodong Zhu · Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2016-06-30
Completion
2016-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02903498 on ClinicalTrials.gov